Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul:96:618-620.
doi: 10.1016/j.ijid.2020.05.065. Epub 2020 May 26.

Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification

Qiang Wang  1 , Zhao Hu  2
Affiliations
Case Reports

Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification

Qiang Wang et al. Int J Infect Dis. 2020 Jul.

Abstract

COVID-19 associated cytokine storm could rapidly induce ARDS, and the patients would require mechanical ventilation. However, the prognosis was not that optimistic. The outcome might be changed if the timely intervention of EBP was performed. We present a case of severe SARS-CoV-2 infection who recovered from a cytokine storm.

Keywords: ARDS; COVID-19; Cytokine storm; Extracorporeal blood purification.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The changes of cytokines and FDPs and the medications applied. The left vertical axis represents the levels of interleukin 2 (IL-2, blue dot) and fibrinogen degradation products (FDPs, purple dot). The right vertical axis represents the levels of interleukin 6 (IL-6, red dot) and interferon γ (INF γ, green dot). The horizontal axis shows the illness days. The gray vertical bar shows the artificial liver therapy. The horizontal bars with different colors represent the medications, and the lengths represent the corresponding duration. Lh Qw denotes the Lianhua Qingwen capsule.
See this image and copyright information in PMC

References

    1. Bartlett R.H., Ogino M.T., Brodie D., McMullan D.M., Lorusso R., MacLaren G. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J. 2020;66(5):472–474. - PMC - PubMed
    1. Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574–1581. - PMC - PubMed
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.J., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. - PMC - PubMed
    1. Honore P.M., Hoste E., Molnar Z., Jacobs R., Joannes-Boyau O., Malbrain M.L.N.G. Cytokine removal in human septic shock: where are we and where are we going? Ann Intensive Care. 2019;9(1):56. - PMC - PubMed
    1. Honore P.M., De Bels D., Barreto Gutierrez L., Spapen H.D. Hemoadsorption therapy in the critically ill: solid base but clinical haze. Ann Intensive Care. 2019;9(1):22. - PMC - PubMed

Publication types